Document is current
Any future updates will be listed below
-
Authors
de Boer, Nini https://orcid.org/0000-0002-4956-3555
Hanskamp, Iris
Lin, Bochao Danae https://orcid.org/0000-0002-4161-8021
Boonstra, Liese
van der Horst, Marte
van Eijk, Kristel
Boks, Marco P. https://orcid.org/0000-0001-6163-7484
Peyrot, Wouter J.
Twisk, Jos
Goldschmidt, Thomas https://orcid.org/0000-0003-2948-0362
Pijl, Hanno
Vinkers, Christiaan H. https://orcid.org/0000-0003-3698-0744
Correll, Christoph U. https://orcid.org/0000-0002-7254-5646
De Hert, Marc https://orcid.org/0000-0003-4255-5920
Guloksuz, Sinan https://orcid.org/0000-0002-6626-1874
Cahn, Wiepke
Luykx, Jurjen J. https://orcid.org/0000-0002-6439-2774
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 3 March 2026
First Online: 6 May 2026
Competing interests
: C.U.C. has been a consultant and/or advisor to or has received honoraria from AbbVie, Alkermes, Allergan, Angelini, Aristo, Autobahn, Axsome, Boehringer-Ingelheim, Bristol-Meyers Squibb, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Delpor, Denovo, Draig, Eli Lilly, EuMentis Therapeutics, Gedeon Richter, GH Research, Hetero, Hikma, Holmusk, Intra-Cellular Therapies, Jamjoom Pharma, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedinCell, MedLink Global, Merck, Mindpax, Mitsubishi Tanabe Pharmaceuticals, MapLight, Mylan, Neumora Therapeutics, Neuraxpharm, Neurocrine, Neurelis, Neurosterix, NeuShen, Neusignal Therapeutics, Newron, Noven, Novo Nordisk, Orion Pharma, Otsuka, PPD Biotech, Recognify Life Sciences, Recordati, Relmada, Response Pharmaceuticals, Reviva, ROVI, Saladax, Sanofi, Seqirus, Servier, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Tabuk, Takeda, Teva, TERRAN, Tolmar, Vertex, Viatris and Xenon Pharmaceuticals. He provided expert testimony for Janssen, Lundbeck, Neurocrine and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, IntraCellular Therapies, Relmada, Reviva and ROVI. He has received grant support from Boehringer-Ingelheim, Janssen and Takeda. He received royalties from UpToDate and is also a stock option or stock holder of Cardio Diagnostics, Küleon Biosciences, LB Pharmaceuticals, MedLink Global, Mindpax, Quantic and TERRAN. The other authors declare no competing interests.
